Comparing Semler Scientific (NASDAQ:SMLR) and Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics (OTCMKTS:ECTE) and Semler Scientific (NASDAQ:SMLR) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent recommendations for Echo Therapeutics and Semler Scientific, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Echo Therapeutics	0	0	0	0	0.00
Semler Scientific	0	0	1	0	3.00

Semler Scientific has a consensus price target of $71.00, suggesting a potential upside of 94.41%. Given Semler Scientific’s stronger consensus rating and higher possible upside, analysts clearly believe Semler Scientific is more favorable than Echo Therapeutics.

Institutional & Insider Ownership

49.4% of Semler Scientific shares are owned by institutional investors. 7.0% of Echo Therapeutics shares are owned by insiders. Comparatively, 30.2% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Echo Therapeutics and Semler Scientific”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Echo Therapeutics	N/A	N/A	N/A	N/A	N/A
Semler Scientific	$56.29 million	6.23	$20.58 million	$4.91	7.44

Semler Scientific has higher revenue and earnings than Echo Therapeutics.

Profitability

This table compares Echo Therapeutics and Semler Scientific’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Echo Therapeutics	N/A	N/A	N/A
Semler Scientific	72.65%	50.77%	47.04%

Summary

Semler Scientific beats Echo Therapeutics on 9 of the 9 factors compared between the two stocks.

About Echo Therapeutics

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.

About Semler Scientific

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.